Combination therapy for advanced hepatocellular carcinoma: do we see the light at the end of the tunnel?
Article 2021 en
Authors
TZ
Ti Zhang
PM
Philippe Merle
HW
Huaqi Wang
Abstract
1 min read
Comprehensive understanding of the mechanism of immunotherapy and targeted therapy contributes to better prognosis of advanced HCC and more explorative combination therapies are needed.
Discussion(0)
No comments yet. Be the first to comment.